Preço máximo de venda foi definido pela Câmara de Regulação do Mercado de Medicamentos, mas falta o anúncio do valor final para consumidores ...

Previsto para chegar ao mercado brasileiro em junho, o Mounjaro (tirzepatida) ainda não teve preço definido pela farmacêutica ...

Remédio usado para tratar a diabetes do tipo 2 e também contra a obesidade é fabricado pela Eli Lilly. Leia no Poder360.

A caneta, concorrente do Ozempic, havia sido aprovada pela Anvisa em 2023, mas ainda não estava disponível no país ...

Scott Disick faced those Mounjaro rumors head on when he admitted to using the weight loss drug. “It shows the Mounjaro? You’re lying!” Scott told Khloé, 40, when she called with the news.

Mounjaro (tirzepatide) is a brand-name injection prescribed for type 2 diabetes in adults. As with other drugs, Mounjaro can cause side effects, such as nausea, diarrhea, and appetite loss ...

Mounjaro (tirzepatide) is a prescription drug that may be prescribed off-label for weight loss. The drug isn’t approved for this use, but it may be helpful for weight management. Mounjaro comes ...

O medicamento Mounjaro (tirzepatida), da farmacêutica Eli Lilly, vai chegar às farmácias brasileiras 7 de junho. A caneta, concorrente do Ozempic (semaglutida), foi aprovada pela Anvisa em 2023, mas a ...

Mounjaro is prescribed for type 2 diabetes. It's a brand-name drug, and it's not available as a generic medication. The drug is given as an injection under the skin. The cost of Mounjaro can vary ...

Wegovy (semaglutide) and Mounjaro (tirzepatide) are brand-name injections. Wegovy is prescribed for weight loss and to lower cardiovascular risks. Mounjaro is approved for type 2 diabetes ...

When James Norris, a 56-year-old mechanic from Roxbury, New Jersey, went on a low dose of Mounjaro, a GLP-1 medication similar to Ozempic, to lose weight in March 2023, he thought it would be a ...